As the Japanese legal entity of Hongyi Investment Group, Ryoshi Investment deeply understands the uniqueness and opportunities of both Chinese and Japanese markets. We have designed three major partnership models to provide customized solutions for companies in different industries and at different development stages.
We possess rich cross-border investment experience and professional teams, capable of helping Chinese and Japanese companies overcome language, cultural, and regulatory barriers to achieve international business expansion and bidirectional technology transfer. Whether you are seeking investment, technological cooperation, or market expansion, we can provide comprehensive support.
Three major cooperation paths designed for Japanese market characteristics, meeting different companies' cross-border development needs
Assisting Japanese advanced technology commercialization in Chinese market
Japan possesses numerous cutting-edge technologies, but sometimes needs broader markets and more flexible application scenarios for commercialization and market promotion. Through this model, we help Japanese technology companies maximize technology value in the Chinese market.
Professional evaluation of Japanese technologies, screening those with commercialization potential in the Chinese market
Finding the most suitable partners in China, possibly manufacturers, distributors, or joint R&D institutions
Providing comprehensive IP protection strategies to ensure technology safety during cross-border transfer
Designing optimal business models and profit schemes based on Chinese market characteristics
Providing specialized PMDA certification services for Chinese medical devices
Medical products are a key area of China-Japan cooperation, but cross-border certification of medical devices has always been a challenge for companies. With our deep accumulation in the healthcare sector, we have established a specialized PMDA certification support team to help Chinese medical products smoothly enter the Japanese market.
Pre-assessment of products against PMDA standards, clarifying certification pathways and timelines
Providing professional medical field translation services to ensure documents comply with Japanese regulatory requirements
Acting as intermediary with PMDA, answering inquiries, accelerating approval processes
Assisting in arranging clinical trials in Japan, providing hospital resource connections
Building China-Japan cross-border M&A bridges
China and Japan have strong complementarity in certain fields, and cross-border M&A can achieve 1+1>2 synergy effects. We provide full-process M&A consulting and services for both parties, helping companies achieve strategic integration.
Screening suitable M&A targets in both Chinese and Japanese markets based on strategic needs
Organizing professional teams for cross-border financial due diligence, evaluating true value
Designing tax and legally optimal transaction structures, reducing transaction risks
Providing post-M&A cultural integration and management integration consulting services
Detailed understanding of client needs, determining suitable partnership models
Developing personalized cooperation plans based on client situations
Connecting relevant resources from both China and Japan, facilitating cooperation
Professional teams providing full-process project execution assistance
Providing long-term market and operational support